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Retinopathy of prematurity (ROP), a well-known complication of preterm birth that can result in avoidable blindness and visual
impairment, is especially sensitive to the quality of neonatal inpatient care and appropriate, well-monitored oxygen. In 2010, the annual
incidence of blindness and visual impairment from ROP was estimated to be 32,200 cases worldwide. The greatest burden is seen in
middle-income countries, particularly where coverage of neonatal inpatient care has expanded without due attention to the quality of care
provided, and the neonatal nursing skills and training of those providing this care. India accounted for nearly 10% of all estimated
worldwide visual impairment following ROP in 2010, with at least 5,000 developing severe disease and 2,900 children surviving with
visual impairment related to ROP. Screening all those at risk and providing treatment for those with severe disease will require investment
to increase the capacities and competencies of eye-care providers. Scale-up of neonatal services must be coupled with implementation
of standards for high quality care, including safe oxygen management, and detection and treatment of ROP. Otherwise the number of
children surviving preterm birth with visual impairment secondary to ROP will continue to increase in India and worldwide.
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Retinopathy of prematurity (ROP), a vision-threatening disease associated with abnormalretinal vascular development, is a well-knowncomplication of preterm birth [1]. It has
increasingly been recognised as an important cause of
avoidable  blindness and visual impairment in children in
Eastern Europe and Latin America, and is becoming a
public health concern in many Asian countries, including
India, China and Malaysia [2,3]
The Millennium Development goal era has seen
unprecedented increases in child survival globally. An
estimated 12.7 million children died before their 5th
birthday in 2000 [4]; in 2015, the number had reduced to
5.9 million. The progress has been most rapid for children
over 1 month of age, and 45% of all child deaths now occur
in the first month of life [4]. Direct complications of
preterm birth are now the commonest causes of child death,
with respiratory distress syndrome the most common
complication [5]. This has led to focused efforts to address
the challenge of neonatal mortality from the global
community, leading to the Every Newborn Action Plan
launched in 2014 – a multi-partner movement that aims to
end preventable newborn deaths and stillbirths [6,7].  An
estimated 15 million babies are born preterm (<37 weeks of
completed gestational age) each year [8] and at least 32
million babies are small for gestational age (<10th centile
for gestational age) [9]. These babies have higher risks of
complications, and requirements for specialised neonatal
care to improve their survival. It is estimated that 80% of all
neonatal deaths occur in babies that are either preterm,
small for gestational age, or both [7].
In response to this, many middle-income countries,
including India, are rapidly expanding their neonatal
inpatient care services, increasing access to supportive and
therapeutic services to address the common complications
experienced by preterm babies, including respiratory
distress syndrome. This had led to a higher number of
preterm babies surviving due to improved respiratory
support, including the use of oxygen. ROP is especially
sensitive to the quality of neonatal care, including
appropriate, well-monitored oxygen. Therefore, unless
scale-up of neonatal services are coupled with
improvements in implementation of standards for high-
quality care and detection and treatment of ROP, the
number of children surviving preterm birth with visual
impairment secondary to ROP will continue to increase.
This article presents a broad overview of blindness due
to ROP globally and in India as part of a special issue
dedicated to the specific challenges of ROP in India.
WHAT IS KNOWN?
The introduction of widespread specialized neonatal care
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in high-income settings, including unmonitored oxygen, in
the 1940s and 1950s led to a large number of moderately
preterm babies surviving with visual impairment
secondary to ROP (the first epidemic) [10].  In recent
decades, sight-threatening ROP has been confined to the
most preterm (<28 weeks) in these settings; however, the
numbers affected have not decreased due to the increase in
survival of extremely preterm babies (the second
epidemic). Attention has now shifted to the growing
number of affected children in low- and middle-income
settings (the third epidemic) [3].
The prevalence of visual impairment secondary to
ROP varies substantially by setting and is dependent upon
the preterm birthrates, the survival of babies born preterm,
the quality of neonatal care and the availability of timely
screening and treatment, if required. Survival of babies
born preterm is closely linked to the quality of neonatal
care and to resource and staffing levels, especially nurses
[11]. Facilities with poor practice for monitoring and
control of oxygen levels may have reasonable survival
levels amongst preterm babies, but high rates of adverse
neuro-developmental outcomes, including ROP
[10,12,13].
Several attempts to quantify the global burden of ROP
have been made. Initial estimates, based on data from
schools for the blind together with blindness prevalence
estimates suggested that at least 50,000 children aged up to
15 years were blind from ROP worldwide [3].  More
recent work suggest that this is likely to be an
underestimate with an estimated 32,200 infants becoming
blind or visually impaired from ROP in 2010 alone [12].
The latter estimate was derived using data from 66 peer-
reviewed publications, meta-analyses, and modelling,
using assumptions from the meta-analyses for countries
without or with incomplete data. Data from five Indian
studies were included. Available data suggests that
blindness from ROP may be increasing, especially in
middle income settings [14,15]. However, the uncertainty
in existing estimates is part of a wider data-gap on the
neuro-developmental outcomes of preterm and sick
newborns, as well as a lack of accurate data on gestational
age and birthweight [16].
Global Update
Fig. 1 shows the estimated distribution of the incidence of
new cases of visual impairment due to ROP per 100,000
livebirths in 2010. Several patterns are noted. In settings
with very high neonatal mortality and low coverage of
neonatal inpatient care, few cases of ROP or resulting
visual impairment occur, with rates of visual impairment
secondary to ROP <10 per 100,000 livebirths.
Two groups of countries have low-moderate
incidences of visual impairment secondary to ROP (rates
of 10 - <45 per 100,000 livebirths), these include:
(i) Low neonatal mortality settings, such as in the United
States of America and the United Kingdom, where
ROP is predominantly found in the extremely preterm
survivors. This is usually detected through screening
programmes, but some visual impairment occurs
despite treatment. Overall rates in these settings are
fairly static; and
(ii) Higher neonatal mortality settings where the survival
rates after preterm birth are increasing, but where
insufficient priority has been given to quality of
neonatal care, or establishment of screening detection
and treatment services for ROP, as in India and other
middle-income countries. Overall rates in these
settings are increasing.
A final group of countries have high rates of ROP (>45
per 100,000 livebirths). These countries are
predominantly middle-income particularly where
coverage of neonatal inpatient care has expanded without
due attention to the quality of care provided, and the
neonatal nursing skills and training of those providing this
care [12,13].
Two thirds of all cases of visual impairment secondary
to ROP in 2010 were estimated to occur in 10 countries –
China, India, Brazil, Indonesia, Iran, Russian Federation,
USA, Mexico, Thailand and Turkey. These countries also
experience the greatest burden of long-term neuro-
developmental disability in survivors following preterm
birth [13].
Update on Levels of ROP in India
India accounted for nearly 10% of the worldwide estimate
of blindness and visual impairment due to ROP in 2010
[12].  In 2010, there were an estimated to be 3,519,100
preterm births in India (uncertainty range: 2,553,100-
4,431,900) [8] using the approach previously used to
estimate the regional and global burden of neonatal
morbidity [12]. If 30% of babies had access to specialised
inpatient neonatal care (intensive care or neonatal special
care) and gestation-specific survival rates amongst these
admitted were similar to reported rates from other low-
middle income country settings, 98,077 babies would have
survived neonatal care and be at risk of visual impairment
from  ROP. Among the survivors, an estimated 16,000
would develop any ROP, with 5,000 (uncertainty range:
2,200-8,000) developing severe (type 1) disease requiring
treatment. Assuming that 20% of these had access to
screening and treatment an estimated 2,900 (uncertainty
range: 2,000-4,000) babies would have survived in 2010
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with visual impairment or blindness due to ROP; the
majority (2,100) being severely affected [12].
Since 2010, India has continued to make important
strides to further improve the coverage of neonatal care,
with operationalization of over 500 special newborn care
units at district level and nearly 2000 newborn stabilisation
units at block level. However, unless adequate attention is
given to the quality of care and screening, detection and
treatment of ROP, these numbers are likely to continue to
increase.
IMPLICATIONS FOR SERVICE DELIVERY
The estimate of 98,077 survivors represents the minimum
number of infants who require screening for ROP, as it does
not include sick, more mature  infants who also need to be
screened. Using the figure of almost 100,000, and if each
infant requires an average of three retinal examinations
before they require treatment or can safely be discharged
from further follow up, this would entail approximately
300,000 examination sessions a year. If both eyes of all
5000 infants estimated to develop severe ROP were to be
treated with peripheral retinal laser, and each eye requires
an hour of an ophthalmologists time, this represents 2,500
working days of highly skilled ophthalmologists’ time.
Another paper in this special issue presents the findings
of a situation analysis of services provided for ROP by 30
tertiary-level eyecare training institutions in 11 major cities
in India.  Twenty-four provided a service for ROP, 15 of
whom screened in only one neonatal unit. The mean
number of infants treated annually for ROP was 39 (range
1-200).
ROP prevention, detection and treatment globally:
Increasing attention and research funding has been
directed to preterm birth prevention over the past five
years [17-19]. However, to date, limited progress has been
made, in part, due to the complexity of the preterm birth
syndrome, coupled with a limited understanding of the
mechanisms controlling normal birth timing in humans.
Attention to the quality of maternity and neonatal care has
also increased, with recognition that it will be essential to
end preventable deaths and reduce morbidities such as
ROP [20].  Standardised guidelines, for example the new
WHO preterm guidelines and Neonatal Networks can play
an important role in achieving this [21,22].
Close attention to the development of adequate
screening and treatment of ROP programs as countries
such as India, introduce and scale-up access to specialised
inpatient neonatal care will be imperative to monitor and
mitigate the potential effects of this ROP epidemic.
Scaling up screening and treatment to reach all babies at
risk in a given population will require innovative
approaches. Screening by members of the neonatal team
using new imaging systems is now on the horizon [23].
CONCLUSION
The burden of visual impairment following ROP globally
is large and increasing, especially in low- and middle-
income settings, including India. India has played a trail-
blazing role in the efforts to scale-up inpatient care for
preterm newborns, backed by a comprehensive India
Newborn Action Plan and exemplary data monitoring
systems. The scale-up of specialized neonatal care is
FIG.1 Estimated global burden of visual impairment from retinopathy of prematurity in 2010.
Data source: National level estimates of ROP burden Blencowe, et al. 2013(12); *low mortality setting = neonatal mortality rate
<5 per 1,000 livebirths; Higher mortality setting=neonatal mortality rate 5 or more per 1,000 livebirths.
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welcomed, in India and other low and middle-income
countries, but there is a need to minimize the potentially
negative impact of preterm birth on these vulnerable
survivors. This requires careful attention to the quality of
inpatient care, backed by comprehensive policies and
guidelines, including safe oxygen monitoring and delivery
mechanisms. High quality inpatient care cannot be
achieved in India without specialized training for neonatal
staff, especially neonatal nurses. As ROP is largely
preventable, rates of ROP are an important indicator of the
quality of inpatient care available for preterm babies.
Rates of ROP are also an important indicator of a system’s
ability to provide ongoing neuro-developmental care into
early childhood. To avoid an increasing epidemic of visual
impairment secondary to ROP, India’s health system must
include ROP screening and detection as part of their
comprehensive child health programs.
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